pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jul 30·1 min read
save

Trump's CDC nominee Erica Schwartz clears key Senate committee vote

Jul 30, 2026·read at Endpoints ↗RegulatoryNeutral

Erica Schwartz, a former deputy surgeon general, was nominated by the Trump administration to lead the CDC.

On July 15, 2026 she testified before the Senate Health, Education, Labor and Pensions Committee, and the committee voted to advance her nomination.

The vote moves her nomination to the full Senate, where supporters expect confirmation, signaling continuity in the administration's public‑health leadership.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Trump's CDC pick Erica Schwartz clears crucial vote in Senate”

read at Endpoints ↗
98 words · retrieved Jul 30
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1h agoAnthropic buys a single-person biotech startup backed by Atlas VentureEndpoints
  • 3h agoBacked by Amish and Mennonites, a new kind of gene therapy company takes shapeEndpoints
  • 5h agoDraft COINS rules could threaten broad China collaborationsEndpoints
  • 5h agoLilly's ads can continue after Novo challenge, judge rulesEndpoints
  • 8h agoGubra looks beyond metabolism, hopes for first portfolio company this yearEndpoints